Sign In
Buy REGN
$618.95
+16.03 (+2.66%)
At Close: Jun 03, 2026
Compass Wealth Management LLC Buys Shares of 3,634 Regeneron Pharmaceuticals, Inc. $REGN
04:48am, Tuesday, 27'th Jan 2026
Compass Wealth Management LLC purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) in the third quarter, according to the company in its most recent Form 13F filing wit
Chicago Partners Investment Group LLC Makes New Investment in Regeneron Pharmaceuticals, Inc. $REGN
03:50am, Monday, 26'th Jan 2026
Chicago Partners Investment Group LLC purchased a new stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) in the undefined quarter, according to the company in its most recent disclosure
Regeneron: Q4 Earnings Preview - Why I'm Expecting A Beat And Strong 2026
03:25pm, Friday, 23'rd Jan 2026
Regeneron Pharmaceuticals, Inc. is approaching a pivotal earnings report following a strong JP Morgan Healthcare Conference update. I maintain a Buy rating on REGN, supported by a >16% share price gai
REGN or ILMN: Which Is the Better Value Stock Right Now?
12:41pm, Friday, 23'rd Jan 2026
Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Regeneron (REGN) and Illumina (ILMN). But which of these two stocks presents investors w
Regeneron (REGN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
11:01am, Friday, 23'rd Jan 2026
Regeneron (REGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives Average Rating of “Moderate Buy” from Brokerages
02:48am, Friday, 23'rd Jan 2026
Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN - Get Free Report) have earned an average rating of "Moderate Buy" from the twenty-eight brokerages that are presently covering the stock, Marke
2 Healthcare Stocks Poised for a Comeback in 2026
01:05pm, Thursday, 22'nd Jan 2026
Don't wait too long to press the buy button on these comeback stories.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:55am, Thursday, 22'nd Jan 2026
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Nation's Top 40 High School Scientists to Compete for $1.8 Million in Awards at the Prestigious Regeneron Science Talent Search
12:05pm, Wednesday, 21'st Jan 2026
Society for Science & Regeneron announced the finalists in the Regeneron Science Talent Search, the nation's oldest and most prestigious STEM competition
Fiduciary Family Office LLC Takes Position in Regeneron Pharmaceuticals, Inc. $REGN
05:38am, Sunday, 18'th Jan 2026
Fiduciary Family Office LLC acquired a new stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) during the undefined quarter, according to its most recent Form 13F filing with the Securit
Dillon & Associates Inc. Decreases Holdings in Regeneron Pharmaceuticals, Inc. $REGN
04:54am, Friday, 16'th Jan 2026
Dillon and Associates Inc. lessened its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) by 63.3% in the undefined quarter, according to the company in its most recent 13F filing w
Market Today: TSMC beat, Goldman soars, Spotify hikes
05:35pm, Thursday, 15'th Jan 2026
Stock News Verizon issues credits after outage: Verizon (VZ) said it resolved a nationwide wireless outage and will offer a $20 account credit to affected custo
Regeneron Pharmaceuticals, Inc. (REGN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
08:16pm, Monday, 12'th Jan 2026
Regeneron Pharmaceuticals, Inc. (REGN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Final Trades: Capital One, UnitedHealth, Regeneron and Alibaba
01:30pm, Monday, 12'th Jan 2026
The Investment Committee give you their top stocks to watch for the second half.
New York State Teachers Retirement System Has $48.69 Million Holdings in Regeneron Pharmaceuticals, Inc. $REGN
06:39am, Monday, 12'th Jan 2026
New York State Teachers Retirement System lowered its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) by 1.1% in the third quarter, according to its most recent 13F filing with the S
